Follow Slashdot stories on Twitter

 



Forgot your password?
typodupeerror
For the out-of-band Slashdot experience (mostly headlines), follow us on Twitter, or Facebook. ×
Biotech Medicine

FDA Approves Vaccine For Prostate Cancer 194 194

reverseengineer writes "The US Food and Drug Administration has given its first first approval for a therapeutic cancer vaccine. In a clinical trial 'involving 512 men, those who got Provenge (sipuleucel-T) had a median survival of 25.8 months after treatment, while those who got a placebo lived a median of 21.7 months. After three years, 32 percent of those who got Provenge were alive, compared with 23 percent of those who got the placebo. ... "The big story here is that this is the first proof of principle and proof that immunotherapy works in general in cancer, which I think is a huge observation," said Dr. Philip Kantoff, chief of solid tumor oncology at the Dana-Farber Cancer Institute in Boston and the lead investigator in Dendreon's largest clinical trial for the drug. "I think this is a very big thing and will lead to a lot more enthusiasm for the approach."'"
This discussion has been archived. No new comments can be posted.

FDA Approves Vaccine For Prostate Cancer

Comments Filter:

If a 6600 used paper tape instead of core memory, it would use up tape at about 30 miles/second. -- Grishman, Assembly Language Programming

Working...